Recession coverage using Amnion Chorion membrane versus SCTG
Not Applicable
Recruiting
- Conditions
- Oral HealthPeriodontitis
- Registration Number
- PACTR201512001047611
- Lead Sponsor
- Manar Taher Elzanaty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Older than 18 years
Systematically healthy patients
Facial recession Miller I or II
Clinical indication for gingival coverage
Good Oral hygiene
Medically free
Exclusion Criteria
Miller class III and IV
Medically compromised
Smokers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie amnion chorion membrane's efficacy in gingival recession coverage compared to subepithelial connective tissue grafts?
How does the use of amnion chorion membrane compare to standard-of-care subepithelial connective tissue grafts in periodontitis treatment outcomes?
Are there specific biomarkers that predict successful gingival recession coverage with amnion chorion membrane versus SCTG in periodontal therapy?
What are the known adverse events and management strategies for amnion chorion membrane application in oral health interventions?
What combination therapies or alternative biomaterials show promise in gingival recession coverage alongside amnion chorion membrane research?